Does SACUBITRIL\VALSARTAN Cause Salivary hypersecretion? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Salivary hypersecretion have been filed in association with SACUBITRIL\VALSARTAN. This represents 0.0% of all adverse event reports for SACUBITRIL\VALSARTAN.
17
Reports of Salivary hypersecretion with SACUBITRIL\VALSARTAN
0.0%
of all SACUBITRIL\VALSARTAN reports
2
Deaths
3
Hospitalizations
How Dangerous Is Salivary hypersecretion From SACUBITRIL\VALSARTAN?
Of the 17 reports, 2 (11.8%) resulted in death, 3 (17.6%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SACUBITRIL\VALSARTAN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does SACUBITRIL\VALSARTAN Cause?
Hypotension (11,718)
Death (9,605)
Dyspnoea (8,952)
Dizziness (8,548)
Fatigue (8,172)
Wrong technique in product usage process (8,022)
Cough (7,743)
Weight decreased (5,030)
Cardiac failure (4,504)
Malaise (4,299)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which SACUBITRIL\VALSARTAN Alternatives Have Lower Salivary hypersecretion Risk?
SACUBITRIL\VALSARTAN vs SAFINAMIDE
SACUBITRIL\VALSARTAN vs SAIZEN
SACUBITRIL\VALSARTAN vs SALICYLATE
SACUBITRIL\VALSARTAN vs SALICYLIC ACID
SACUBITRIL\VALSARTAN vs SALMETEROL